The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 03, 2017

Filed:

Aug. 23, 2006
Applicants:

John Biggerstaff, Oak Ridge, TN (US);

Brandy Weidow, Knoxville, TN (US);

Inventors:

John Biggerstaff, Oak Ridge, TN (US);

Brandy Weidow, Knoxville, TN (US);

Assignee:

ENSION INC., Pittsburgh, PA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/75 (2006.01); C07K 14/705 (2006.01); G01N 33/50 (2006.01); G01N 33/569 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/75 (2013.01); C07K 14/70525 (2013.01); C07K 14/70553 (2013.01); G01N 33/5044 (2013.01); G01N 33/56972 (2013.01); A61K 38/00 (2013.01);
Abstract

The present invention demonstrated that soluble fibrin binds to both Mac-1 and ICAM-1-expressing cells and inhibited adherence of these cells and immune cytotoxicity, thus inducing immune suppression in cancer. Additionally, the present invention also demonstrated that soluble fibrin enhanced metastasis in an in vivo model. Furthermore, the present invention demonstrated the utility of specific peptides that block binding of soluble fibrin to these cells as therapeutic agents in cancer progression and metastasis. It is further contemplated that these peptides can also be used to treat other diseases such as cardiovascular disease, arthritis and in many inflammatory responses where there is increased levels of soluble fibrin.


Find Patent Forward Citations

Loading…